Suppr超能文献

The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background.

作者信息

Sun Hui-Chuan, Tang Zhao-You, Ma Zeng-Chen, Qin Lun-Xiu, Wang Lu, Ye Qin-Hai, Fan Jia, Wu Zhi-Quan, Zhou Xin-Da

机构信息

Liver Cancer Institute and Zhong Shan Hospital, Fudan University, 200032 Shanghai, PR China.

出版信息

J Cancer Res Clin Oncol. 2005 May;131(5):284-8. doi: 10.1007/s00432-004-0645-9. Epub 2005 Jan 21.

Abstract

PURPOSE

Second resection has been proved to be a safe and effective treatment for patients with intrahepatic recurrent HCC after primary resection; however, preoperative prognostic factors for outcome following second resection in patients with a hepatitis B virus (HBV) infection background remains to be clarified.

METHODS

Fifty-seven patients with intrahepatic recurrent an HCC and HBV infection background received second resection from 1997 to 2003 in our institute. All of them were negative for anti-hepatitis C virus (HCV) and positive regarding HBV profile. Patient and tumor factors were analyzed.

RESULTS

At the time of preparing this paper, 31 had re-recurrence and 21 patients had died. No postoperative mortality was noted. The 1-, 3-, and 5-year overall survival after second resection were 69.9%, 61.2%, and 30.6%, respectively. Univariate and multivariate analysis showed that vascular invasion and time to recurrence were the independent prognostic factors for overall survival following second resection. The 3- and 4-year overall survival after second resection were 57.7% and 46.6% in patients with the presence of any of two risk factors (n = 46), and 100% and 100% in those with absence of both risk factors (n = 11, P = 0.008).

CONCLUSIONS

Vascular invasion and time to recurrence were the prognostic factors for overall survival following second resection of intrahepatic recurrent HCC.

摘要

相似文献

4
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
5
Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.
J Cancer Res Clin Oncol. 2017 Feb;143(2):293-303. doi: 10.1007/s00432-016-2286-1. Epub 2016 Oct 14.
7
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Cochrane Database Syst Rev. 2015 Jan 26;1(1):CD006745. doi: 10.1002/14651858.CD006745.pub3.
9
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD011645. doi: 10.1002/14651858.CD011645.pub2.

引用本文的文献

1
Current status and prospect of treatments for recurrent hepatocellular carcinoma.
World J Hepatol. 2023 Feb 27;15(2):129-150. doi: 10.4254/wjh.v15.i2.129.
2
3
Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature.
Front Oncol. 2022 Jan 31;12:832405. doi: 10.3389/fonc.2022.832405. eCollection 2022.
5
Is the anatomical resection necessary for single hepatocellular carcinoma smaller than 3 cm?: single-center experience of liver resection for a small HCC.
Ann Hepatobiliary Pancreat Surg. 2018 Nov;22(4):326-334. doi: 10.14701/ahbps.2018.22.4.326. Epub 2018 Nov 27.

本文引用的文献

2
Very late relapse of medulloblastoma.
Folia Neuropathol. 2004;42(1):49-53.
3
Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
J Am Coll Surg. 2003 Nov;197(5):759-64. doi: 10.1016/S1072-7515(03)00750-6.
4
Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
J Am Coll Surg. 2003 Nov;197(5):753-8. doi: 10.1016/j.jamcollsurg.2003.07.003.
6
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
Ann Surg. 2003 Nov;238(5):703-10. doi: 10.1097/01.sla.0000094549.11754.e6.
7
Surgical treatment of hepatocellular cancer in the era of hepatic transplantation.
J Am Coll Surg. 2003 Jun;196(6):887-97. doi: 10.1016/S1072-7515(03)00140-6.
10
Hepatitis B e antigen and the risk of hepatocellular carcinoma.
N Engl J Med. 2002 Jul 18;347(3):168-74. doi: 10.1056/NEJMoa013215.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验